Xavier Rovira

Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator

ARTICLE.Font J, López-Cano M, Notartomaso S, Scarselli P, Di Pietro P, Bresolí-Obach R, Battaglia G, Malhaire F, Rovira X, Catena J, Giraldo J, Pin JP, Fernández-Dueñas V, Goudet C, Nonell S, Nicoletti F, Llebaria A, Ciruela F. elife. 2017 Apr 11;6. pii: e23545. doi: 10.7554/eLife.23545. Abstract. Light-operated drugs constitute a [...]

  • Molecular Photopharmacology

TR2Lab creates a new research line in Molecular Photopharmacology, leaded by Dr. Xavier Rovira

Proud to create a new research line focused on Molecular Photopharmacology. The recent recruitment of Dr. Xavier Rovira, an expert in the field of optopharmacology, has allowed the TR2Lab creates an emerging research line focused on developing new advanced photopharmacological therapies for cardiovascular diseases. Check out more information under Research

2017-02-28T22:01:13+01:00March 1, 2017|General, Xavier Rovira 2017|
  • Grünenthal Foundation

Xavier Rovira has been awarded the Prize in pain research 2016 by Grünenthal Foundation

Xavier Rovira member of the TR2Lab has received the award for Research in Pain 2016 by the Grünenthal Foundation and the Extraordinary Chair of Pain "Grünenthal Foundation" in the University of Salamanca. This award recognizes the most innovative projects on pain, both epidemiologically as experimental, pharmacological and clinical. In this XVII edition, in the [...]

Proud to incorporate Dr. Xavier Rovira, an expert in light-regulated drugs

Proud to incorporate Dr. Xavier Rovira, an expert in the field of optopharmacology Welcome, Dr. Xavier Rovira Albans, who joins to TR2Lab to develop the area of Molecular Photopharmacology. His expertise in developing research in the emerging field of Optopharmacology will increase the potential of the multidisciplinary TR2Lab team for [...]

2017-07-09T12:52:10+02:00January 9, 2017|2017, General, Xavier Rovira, Xavier Rovira 2017|
  • Opto-cardiac

Opto-cardiac modulation without the need of genetic manipulation using synthetic light- regulated drugs

  GRANT. Project information. Dr. Xavier Rovira has obtained a grant from the Programa Estatal de Investigación, Desarrollo e Innovación Orientada a los Retos de la Sociedad, on the framework of the Plan estatal de Investigación Científica y Técnica y de Innovación 2013-2016, in the modality 3: «proyectos de I+D+I [...]

Go to Top